GCC 2546- Motion Management

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Maryland, Baltimore

About this trial

The purpose of this study is to assess a real time motion tracking of lung tumors and important organs next to the tumor while breathing during a participant's radiation treatment. This will be assessed through a four-dimensional magnetic resonance imaging (MRI) scan before starting your radiation treatment and x-ray fluoroscopy images that are taken during radiation

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult (≥18 years) patients (both sexes) with histologically diagnosed Stage II-IIIb NSCLC

Patients to be treated with definitive external beam photon radiotherapy with or without systemic therapy (e.g., chemotherapy, immunotherapy).

No restrictions on number radiotherapy fractions, or location/number of lesions

ECOG performance status ≤ 3

Disqualifiers

Pre-existing contraindications for MRI, such as any MRI-conditional or MRI-unsafe foreign objects within the body, non-removable ear cochlear or eye implant, aneurysm clip, cardiac pacemaker/wires, internal defibrillator, tissue expander, recent stent placement, penile prosthesis, medication patch, artificial limb, pregnancy, and claustrophobia

Women who are pregnant or trying to get pregnant (self-reported)

Pain in supine position or inability to raise arm above head in supine position

Trial design

Design model

Single group

Treatments tested in this trial

  • MRI

    Other intervention

    Baseline 4D CT Simulation and 4S MRI with surface monitoring through EndoScout vest, followed by fluoroscopy and additional surface monitoring while undergoing daily radiation.

Treatment groups

44 Participants
are divided into 1 treatment group
Group A: ImagingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

To investigate if time-resolved, multicycle volumetric motion modeling and monitoring gives improved spatiotemporal localization of the tumor target and OARs compared to current standard-of-care 4DCT-based motion modeling and monitoring

Time frame
3 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.